A detailed history of Northeast Financial Consultants Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 5,535 shares of BSX stock, worth $461,452. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,535
Previous 6,530 15.24%
Holding current value
$461,452
Previous $447,000 4.7%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$67.33 - $77.71 $66,993 - $77,321
-995 Reduced 15.24%
5,535 $426,000
Q2 2020

Jul 30, 2020

BUY
$30.19 - $39.11 $197,140 - $255,388
6,530 New
6,530 $229,000
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $276,261 - $330,974
-7,295 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $240,078 - $297,271
7,295 New
7,295 $280,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.